This inventor holds 3 USPTO granted patents. Top assignee: Janssen Pharmaceutica Nv. Active years: 2001-2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001-2004
Title: The Innovative Contributions of Marc André Ceusters
Introduction
Marc André Ceusters is a notable inventor based in Diest, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly in the area of angiogenesis inhibition. With a total of three patents to his name, Ceusters has established himself as a key figure in medical research and development.
Latest Patents
Ceusters' latest patents include innovative compounds aimed at inhibiting angiogenesis. The first patent focuses on 5-substituted-1,2,4-thiadiazolyl derivatives, while the second patent explores thiadiazolyl pyridazine derivatives. These inventions are crucial in the ongoing fight against diseases that involve abnormal blood vessel growth.
Career Highlights
Marc André Ceusters is currently employed at Janssen Pharmaceutica NV, a leading pharmaceutical company known for its commitment to innovation and research. His work at Janssen has allowed him to contribute to groundbreaking advancements in drug development and therapeutic solutions.
Collaborations
Throughout his career, Ceusters has collaborated with esteemed colleagues, including Raymond A Stokbroekx and Marcel Jozef Maria Van Der Aa. These partnerships have fostered a collaborative environment that enhances the potential for innovative discoveries.
Conclusion
Marc André Ceusters exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and collaborations continue to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile